Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding *

This publication has 16 references indexed in Scilit:

• CONTRACEPTION WITH AN LHRH AGONIST: EFFECT ON GONADOTROPHIN AND STEROID SECRETION PATTERNS
  Clinical Endocrinology, 1984
• Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis
  Fertility and Sterility, 1984
• Ultrasonic measurement of ovarian follicles during chronic LRH agonist treatment for contraception
  Contraception, 1983
• Gonadotroph and corpus luteum responses to two successive intranasal doses of a luteinizing hormone-releasing hormone agonist at different days after the midcycle luteinizing hormone surge
  Fertility and Sterility, 1983
• Steroid Secretion in Polycystic Ovarian Disease after Ovarian Suppression by a Long-Acting Gonadotropin-Releasing Hormone Agonist*
  Journal of Clinical Endocrinology & Metabolism, 1983
• Fortschritte in der kontrazeptiven Anwendung des LH-RH-Agonisten Buserelin: diskontinuierliche Medikation mit gestageninduzierter Abbruchblutung
  Geburtshilfe und Frauenheilkunde, 1982
• Metabolic Clearance Rates of Luteinizing Hormone in Women during Different Phases of the Menstrual Cycle and While Taking an Oral Contraceptive
  Journal of Clinical Endocrinology & Metabolism, 1982
• Der Einfluß der Dauermedikation des LH-RH-Analogons Buserelin auf die Zyklusregulation
  Geburtshilfe und Frauenheilkunde, 1981
• THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY
  Biochemical Journal, 1963
• Extension of Multiple Range Tests to Group Means with Unequal Numbers of Replications
  Published by JSTOR ,1956